ArticleCancers2022

EGFR-Tyrosine Kinase Inhibitors Induced Activation of the Autocrine CXCL10/CXCR3 Pathway through Crosstalk between the Tumor and the Microenvironment in EGFR-Mutant Lung Cancer.

Sook-Hee Hong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.